Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients.

NCT01224457 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT01224457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01224457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients.
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2008
Completion date
May 31, 2010
Enrollment
52 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal seizure